Thousands of low-income people living with HIV could be losing drug coverage as states impose limitations on HIV assistance programs amid constrained budgets — raising alarms over consistent access to ...
On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...
Prescription costs and coverage hurdles are increasing, leading patients to act as their own payers in a fragmented system. Despite $5 billion annual investment in patient assistance programs, less ...
Jayant Mishra said he was approved for a copay card covering $9,450 a year. He didn't realize how fast the money would run out.
A concerning program by Eli Lilly ties increased copay assistance for one of its top-selling brand-name drugs, tirzepatide (Zepbound), to having a prescription for another, ixekizumab (Taltz). Called ...
Florida's proposed rule change to its AIDS Drug Assistance Program could cut off over 16,000 Floridians from life-saving medication and treatment.
The state invoked emergency rule-making power for what advocates say will be another emergency, when HIV-positive patients lose medication assistance.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results